BioSpace News Archive

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS™) technology, today announced that three clinical studies demonstrating positive results across its dermatologic portfolio are available via webcast at the virtual annual conference of the American Society for Laser Medicine and Surgery (ASLMS).

The Pennant Group, Inc., the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced that it has acquired the assets of two home health agencies and two hospice agencies with multiple locations across Southeastern Idaho and Northern Utah.

Dicerna Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of stock options to purchase a total of 165,800 shares of common stock and 43,300 restricted stock units to be distributed among 15 new employees with a grant date of July 1, 2020.

Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a biotechnology company experienced in anti-viral drug development, today announced that the U.S. Federal Trade Commission (FTC) granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

SmileDirectClub, Inc., the first direct-to-consumer telehealth platform for teeth straightening, announced its continued international expansion with openings in Singapore and Austria.

The National Institutes of Health has announced $75 million in funding to be shared by a coordinating center and a network of 10 other top academic medical centers that will launch a five-year effort to improve genomic risk assessments for diverse populations and integrate their use in clinical care.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today reported that the Compensation Committee of Catalyst’s Board of Directors granted a non-qualified inducement stock option to purchase an aggregate of 140,000 shares of Catalyst’s common stock to Clinton Musil, Catalyst’s recently appointed Chief Financial Officer, effective July 1, 2020

Microbrush, a leading US-based global manufacturer and supplier of flocked applicators, has launched a nasopharyngeal test swab to meet the growing demand for COVID-19 testing requirements.

Drug industry trade group files lawsuit against Minnesota law establishing an emergency fund to help people with diabetes access insulin when they exhaust resources

Inimmune Corporation, a biotechnology company located in Missoula, MT, was recently awarded a $2 M grant from the National Institute for Allergy and Infectious Diseases (NIAID) under its Small Business Innovation Research (SBIR) Direct to Phase II program to advance a novel adjuvant and delivery system for vaccines.